ProMED-mail
ProMED-mail (Program for Monitoring Emerging Diseases) is an internet-based reporting platform that provides rapid and reliable reports on outbreaks of infectious diseases and acute exposures to toxins that affect human health, including those in animals and plants eaten by humans. Initiated in 1994, ProMED-mail is a project of the International Society for Infectious Diseases. Its goal is to provide a comprehensive source of information on emerging diseases that could lead to global epidemics or pandemics. ProMED-mail is open to all sources and encourages the reporting of infectious diseases from all countries. It has become an essential tool for public health professionals, researchers, and policymakers in tracking and responding to disease outbreaks.
Overview
ProMED-mail operates as a global early warning system for emerging diseases and toxins. It collects reports from a wide range of sources, including media reports, official health reports, and contributions from its subscribers. These reports are reviewed and analyzed by a team of moderators who are experts in infectious diseases and epidemiology. The moderators provide commentary and context for the reports, highlighting their significance and potential impact on public health.
Functionality
The platform allows for the rapid dissemination of information through its email subscription service and website. Subscribers receive updates on new reports and can participate in discussions. ProMED-mail covers a broad spectrum of diseases and toxins, including bacterial, viral, and parasitic infections, as well as chemical and radiological exposures.
Significance
ProMED-mail has played a crucial role in the early detection of numerous disease outbreaks. For example, it was among the first to report the outbreak of Severe Acute Respiratory Syndrome (SARS) in 2003, the emergence of H1N1 Influenza (Swine Flu) in 2009, and the Zika virus outbreak in 2015. By providing timely information, ProMED-mail has helped to mobilize international responses to these and other public health threats.
Challenges and Limitations
Despite its successes, ProMED-mail faces challenges, including the verification of reports from unofficial sources and the potential for misinformation. The platform relies on the expertise of its moderators to assess the credibility of reports and provide accurate information. Additionally, there is the challenge of language barriers, as reports come in from around the globe, necessitating translation and interpretation.
Future Directions
ProMED-mail continues to evolve, with efforts to improve its technological infrastructure and expand its network of reporters and experts. The platform is exploring the use of artificial intelligence and machine learning to enhance its ability to detect and report outbreaks. Furthermore, ProMED-mail is working to increase its outreach in regions where reporting on infectious diseases is limited, aiming to provide a more comprehensive global picture of emerging health threats.
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD